Search Result "proline rich Akt substrate 40 kDa (PRAS40)"
Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 65-70
Author(s): Jens R. Larsen, Morten Smerup, Rikke Norregaard, Jane H. Christensen, Kim Sivesgaard, Sara D. Christensen, Karin Christensen, Erik Sloth, Peter Torp, Niels Gregersen, J. Michael Hasenkam
The PKB/AKT Pathway in Cancer
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 34-44
Author(s): Amancio Carnero
Erythropoietin and mTOR: A âOne-Two Punchâ for Aging-Related Disorders Accompanied by Enhanced Life Expectancy
Journal: Current Neurovascular Research
Volume: 13 Issue: 4 Year: 2016 Page: 329-340
Author(s): Kenneth Maiese
The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 3 Year: 2008 Page: 187-198
Author(s): Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link, Juan F.M. Leal
Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 9 Year: 2009 Page: 1024-1038
Author(s): Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka, Osamu Yamada
Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2715-2726
Author(s): A. M. Martelli, C. Evangelisti, M. Y. Follo, G. Ramazzotti, M. Fini, R. Giardino, L. Manzoli, J. A. McCubrey, L. Cocco
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 1 Year: 2010 Page: 29-57
Author(s): Sandra E. Ghayad, Pascale A. Cohen
Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 188-204
Author(s): Thomas W. Grunt, Gabriella L. Mariani
Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 7 Year: 2013 Page: 971-978
Author(s): Xin Tong, Jill C. Pelling
Editorial (Hot Topic: Inhibition of PI3K/Akt/mTOR Signaling by Natural Products)
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 7 Year: 2013 Page: 967-970
Author(s): Shile Huang